Regulation of exit from quiescence by p27 and cyclin D1-CDK4

Molecular and Cellular Biology

Volumn 18, Issue 11, 1998, Pages 6605-6615

  Ladha, Mohamed H ^a   Lee, Kwang Y ^a   Upton, Todd M ^a,c   Reed, Michael F ^a,d   Ewen, Mark E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Cytomatrix Inc   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27;

ARTICLE; CELL CYCLE G1 PHASE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; MITOSIS INHIBITION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0031741554     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.11.6605     Document Type: Article

References (98)

1. KIP1. Mol. Cell. Biol. 17:3850-3857.
2. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D' promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
3. Alessandrini, A., D. S. Chiaur, and M. Pagano. 1997. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11:342-345.
4. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
5. Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56:779-827.
6. Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689.
7. Brunet, A., G. Pages, and J. Pouysségur. 1994. Constitutive active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9:3379-3387.
8. Cai, H., J. Szeberenyi, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10:5314-5323.
9. CIP1 Mol. Cell. Biol. 16:4673-4682.
10. KiP1 by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091-1096.
11. Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine, and J. M. Roberts. 1996. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1979-1990.
12. Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880.
13. Connell-Crowley, L., S. J. Elledge, and W. J. Harper. 1998. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr. Biol. 8:65-68.
14. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
15. de Vries-Smits, A. M. M., B. M. T. Burgering, S. J. Leevers, C. J. Marshall, and J. L. Bos. 1992. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357:602-604.
16. 1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14:5441-5449.
17. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
18. Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
19. Feramisco, J. R., M. Gross, T. Kamata, M. Rosenberg, and R. W. Sweet. 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:109-117.
20. Filmus, J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, and C. J. Conti. 1994. Induction of cyclin D1 overexpression bv activated ras. Oncogene 9:3627-3633.
21. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889-4901.
22. Geng, Y., E. N. Eaton, M. Picon, J. M. Roberts, A. S. Lundberg, A. Gifford, C. Sardet, and R. A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 16:2402-2407.
23. Hall, M., and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:67-108.
24. Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291-5295.
25. Herber, B., M. Truss, M. Beato, and R. Muller. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-1304.
26. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
27. Joneson, T., M. A. White, M. H. Wigler, and D. Bar-Sagi. 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271:810-812.
28. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
29. Kato, J.-Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713-2721.
30. Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev. 7:331-342.
31. Kip1 degradation and anchorage independence through the MAP kinase signaling pathway. Oncogene 15:629-637.
32. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massagué. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536-539.
33. Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 12:426-428.
34. Krude, T., M. Jackman, J. Pines, and R. A. Lasky. 1997. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88:109-119.
35. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fallaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
36. MAPK pathway. J. Biol. Chem. 271:20608-20616.
37. Leng, X., L. Connell-Crowley, D. Goodrich, and J. W. Harper. 1997. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7:709-712.
38. Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 187:422-426.
39. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
40. Liu, J.-J., J.-R. Chao, M.-C. Jiang, S.-Y. Ng, J. J.-Y. Yen, and H. F. Yang-Yen. 1995. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
41. Loda, M., B. Cukor, S. W. Tam, P. Lavin, M. Florentino, G. F. Draetta, J. M. Jessup, and M. Pagano. 1997. Increased proteosome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:231-234.
42. 1 checkpoint. Mol. Cell. Biol. 16:6917-6925.
43. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
44. Lundberg, A. S., and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
45. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
46. Marshall, C. J. 1997. Ras effectors. Curr. Opin. Cell Biol. 8:197-204.
47. Matsuoka, M., J.-Y. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr. 1994. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14:7265-7275.
48. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
49. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
50. Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall. 1997. Ras signalling is required for inactivation of tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7:219-221.
51. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging line. Nucleic Acids Res. 18:3587-3596.
52. Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH3T3 cells. Nature 313:241-243.
53. Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 92:4352-4356.
54. Neuman, E., M. H. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzo, R. G. Pestell, P. W. Hinds, S. F. Dowdy, M. Brown, and M. E. Ewen. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:5338-5347.
55. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
56. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
57. Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
58. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
59. Okuda, K., T. J. Ernst, and J. D. Griffin. 1994. Inhibition of p21ras activation blocks proliferation but not differentiation of interleukin-3-dependent myeloid cells. J. Biol. Chem. 269:24602-24607.
60. Waf1/Cip1. Nature 394: 295-299.
61. Pages, G., P. Lenorman, G. L'Allemain, J.-C. Chambard, S. Meloche, and J. Pouysségur. 1993. Mitogen-activated protein kinase p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319-8323.
62. Pardee, A. B. 1974. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71:1286-1290.
63. Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
64. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
65. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177-181.
66. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
67. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signal. Cell 78:59-66.
68. Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat. Med. 3:222-225.
69. ras in receptor tyrosine kinase signalling. Biochim. Biophys. Acta 1198:131-147.
70. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
71. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
72. Kip1 by cDNA antisense suppresses quiescence (GO state) in fibroblasts. J. Biol. Chem. 271:18337-18341.
73. Robbins, D. J., M. Cheng, E. Zhen, C. A. Vanderbilt, L. A. Feg, and M. H. Cobb. 1992. Evidence for a Ras-dependent extracellular signal-related protein kinase (ERK) cascade. Proc. Natl. Acad. Sci. USA 89:6924-6928.
74. Sellers, W. R., and W. G. Kaelin. 1996. RB as a modulator of transcription. Biochim. Biophys. Acta. 1288:M1-M5.
75. INK4. Science 267:249-252.
76. INK4a. Cell 88:593-602.
77. Kip1. Mol. Cell. Biol. 17:5588-5597.
78. Kip1. Genes Dev. 11:1464-1478.
79. Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
80. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
81. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
82. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
83. Stacey, D. W., L. A. Feig, and J. B. Gibbs. 1991. Dominant inhibitor Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11:4053-4064.
84. Stacey, D. W., and H. F. Kung. 1984. Transformation of NIH 3T3 cells by microinjection of Ha-ras protein. Nature 310:508-511.
85. Szeberenyi, J., H. Cai, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10:5324-5332.
86. Kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:5348-5358.
87. Temin, H. 1971. Stimulation by serum of multiplication of stationary chicken cells. J. Cell. Physiol. 78:161-170.
88. Terada, Y., M. Tatsuka, S. Jinno, and H. Okayama. 1995. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet radiation. Nature 376:358-362.
89. Thomas, S. M., M. DeMarco, G. D'Arcangelo, S. Helegoua, and J. S. Brugge. 1992. Ras is essential for nerve growth factor-and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68:1031-1040.
90. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
91. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
92. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
93. Winston, J., F. Dong, and W. J. Pledger. 1996. Differential modulation of G1 cyclins and the cdk inhibitor p27Kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271:11253-11260.
94. Winston, J. T., S. R. Coats, Y.-Z. Wang, and W. J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic Ras. Oncogene 12:127-134.
95. Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis. 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68:1041-1050.
96. Cip1. Mol. Cell. Biol. 17:5598-5611.
97. Zetterberg, A., O. Larsson, and K. G. Wiman. 1995. What is the restriction point? Curr. Opin. Cell Biol. 7:835-842.
98. Zhao, J., B. Dynlacht, T. Imai, T.-A. Hori, and E. Harlow. 1998. Expression of NPAT, a novel substrate of cyclin E-cdk2, promotes S-phase entry. Genes Dev. 12:456-461.